Research graph
References from Editorial Comment on “Detection of Clinically Significant Prostate Cancer on Systematic Biopsy in Patients with a PI-RADS 3-5 Lesion on MRI: Results from a Large Institutional Series”. Local targets link to admitted publications; unresolved targets remain external evidence.
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
10.1056/nejmoa2209454 · 2022 · External reference
Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions
10.1111/bju.16816 · 2025 · External reference
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
10.1056/nejmoa1910038 · 2020 · External reference
Pathologic Upgrading in Biopsy Grade Group 1, PI-RADS ≥ 3 Prostate Cancer: Factors Associated With Clinically Significant Disease on Radical Prostatectomy
10.1016/j.clgc.2026.102537 · 2026 · External reference
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy
10.1007/s00345-019-02634-9 · 2019 · External reference
PI-RADS–stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy
10.1016/j.euf.2026.04.017 · 2026 · External reference
